RPRX icon

Royalty Pharma
RPRX

Overview Fund Activity

198 hedge funds and large institutions have $11.4B invested in Royalty Pharma in 2020 Q4 according to their latest regulatory filings, with 93 funds opening new positions, 70 increasing their positions, 24 reducing their positions, and 27 closing their positions.

Holders
198
Holders Change
+64
Holders Change %
+47.76%
% of All Funds
3.51%
Holding in Top 10
10
Holding in Top 10 Change
+4
Holding in Top 10 Change %
+66.67%
% of All Funds
0.18%
New
93
Increased
70
Reduced
24
Closed
27
Calls
$18.1M
Puts
$39.4M
Net Calls
-$21.3M
Net Calls Change
-$20.1M

Top Buyers

1
VCG
1
Vantage Consulting Group
Virginia
$1.07B
2
Morgan Stanley
2
Morgan Stanley
New York
$1.19B
3
SGA
3
Siguler Guff Advisers
New York
$338M
4
Fidelity Investments
4
Fidelity Investments
Massachusetts
$1.25B
5
Capital International Investors
5
Capital International Investors
California
$823M

Top Sellers

1
Adage Capital Partners
1
Adage Capital Partners
Massachusetts
$1.94B
2
T. Rowe Price Associates
2
T. Rowe Price Associates
Maryland
$161M
3
BL
3
Bleichroeder LP
New York
$10M
4
Invesco
4
Invesco
Georgia
$10.5M
5
PI
5
Putnam Investments
Massachusetts
$33.3M
Name Market Value Shares Shares
Change 		Shares
Change %
Adage Capital Partners
1
Adage Capital Partners
Massachusetts
$1.94B 38,714,280 -7,301,050 -16%
Fidelity Investments
2
Fidelity Investments
Massachusetts
$1.25B 24,942,548 +6,754,244 +37%
Morgan Stanley
3
Morgan Stanley
New York
$1.19B 23,798,081 +14,431,463 +154%
VCG
4
Vantage Consulting Group
Virginia
$1.07B 21,477,282 +21,477,282 New
Capital International Investors
5
Capital International Investors
California
$823M 16,451,353 +6,077,310 +59%
HMC
6
Harvard Management Company
Massachusetts
$735M 14,690,780 – –
BlackRock
7
BlackRock
New York
$453M 9,053,545 +5,321,913 +143%
SGA
8
Siguler Guff Advisers
New York
$338M 6,761,970 +6,761,970 New
JPMorgan Chase & Co
9
JPMorgan Chase & Co
New York
$304M 6,080,359 +2,329,123 +62%
Wellington Management Group
10
Wellington Management Group
Massachusetts
$294M 5,868,929 +168,816 +3%
Janus Henderson Group
11
Janus Henderson Group
United Kingdom
$245M 4,901,700 +177,056 +4%
CCM
12
CAAS Capital Management
New York
$195M 3,895,885 +3,595,885 +1,199%
Victory Capital Management
13
Victory Capital Management
Texas
$186M 3,707,732 +866,849 +31%
MSKCC
14
Memorial Sloan Kettering Cancer Center
New York
$178M 3,565,887 +3,565,887 New
SCM
15
Suvretta Capital Management
New York
$178M 3,556,933 +744,552 +26%
T. Rowe Price Associates
16
T. Rowe Price Associates
Maryland
$161M 3,209,155 -5,021,895 -61%
State Street
17
State Street
Massachusetts
$118M 2,357,742 +1,339,548 +132%
Viking Global Investors
18
Viking Global Investors
Connecticut
$114M 2,287,000 +338,936 +17%
AAMU
19
Amundi Asset Management US
Massachusetts
$97.5M 1,947,724 +1,947,724 New
Vanguard Group
20
Vanguard Group
Pennsylvania
$92M 1,838,966 +426,080 +30%
TCM
21
TimesSquare Capital Management
New York
$80.5M 1,607,480 +618,970 +63%
GA
22
General Atlantic
New York
$75.1M 1,500,000 – –
HM
23
HealthCor Management
New York
$67M 1,339,530 -156,880 -10%
Geode Capital Management
24
Geode Capital Management
Massachusetts
$62.6M 1,252,507 +167,664 +15%
Franklin Resources
25
Franklin Resources
California
$56M 1,118,204 -73,218 -6%
1
2 3 4 5